Uzma Khan is a public health professional based in Dubai, UAE. She trained in medicine at the Dow University of Health Sciences. She has an MS in Epidemiology and completed the Program in Clinical Effectiveness at the Harvard School of Public Health, along with a research fellowship in MDR-TB at Harvard Medical School’s Program in Infectious Disease & Social Change.
Uzma joined IRD in 2009, managing clinical research and program delivery at our flagship TB control program at the Indus Hospital in Karachi, supporting patient care through training and programmatic monitoring. From 2010-2011, she successfully managed the transition of the Indus Hospital MDR-TB program from a pilot funded by private donors to the Global Fund supported program now spanning to Sindh and Baluchistan provinces.
Since 2011, Uzma has provided technical assistance to the governments of Tajikistan and Nepal to scale up community-based management of MDR-TB and internal monitoring and evaluation of IRD grants from UNDP, WHO and the Stop TB Partnership. Similarly, she had provided technical assistance to IRD partner organizations in Kenya, South Africa and monitoring TB REACH grants targeting private sector providers in Karachi, Dhaka and Jakarta.
Uzma is currently the Project Manager on one of IRD’s largest multi-country consortium grants – endTB. This 4-year project is funded by UNITAID and focuses on introducing new TB drugs (bedaquiline and delaminid) to 15 countries including Bangladesh, Indonesia and Pakistan.
Current role